Nanopore sequencing for clinical genetics: From critical care to complex genomic signatures
- Published on:
Debarshi Mustafi (Seattle Children’s Hospital, USA) discusses how the capabilities of nanopore sequencing could translate into clinical insight in the future. Using examples from inherited retinal disease and retinoblastoma, he will illustrate how long nanopore reads can resolve difficult structural and noncoding variants, phase haplotypes, determine parental origin, and generate methylation data alongside genetic information.
This is independent, investigator-led research using Oxford Nanopore technology. Oxford Nanopore products are for research use only, and not for use in diagnostic procedures.
:quality(80))